hordenine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; He, D; He, Y; Hu, G; Liu, D; Liu, Y; Su, Y; Wang, H; Ye, B | 1 |
| Chen, Z; Fan, S; Gao, M; Huang, C; Huang, X; Jiang, X; Li, F; Li, H; Li, W; Luo, L; Wang, G; Wu, X; Zhang, X; Zhang, Y; Zhou, Z; Zhu, J | 1 |
2 other study(ies) available for hordenine and Parkinson Disease
| Article | Year |
|---|---|
Hordenine inhibits neuroinflammation and exerts neuroprotective effects via inhibiting NF-κB and MAPK signaling pathways in vivo and in vitro.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Lipopolysaccharides; MAP Kinase Signaling System; Microglia; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Rats; Tyramine | 2022 |
Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling.
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Parkinson Disease; Receptors, Dopamine D2; Reproducibility of Results | 2023 |